Cargando…

Parkinson's Disease: From Genetics to Clinical Practice

Breakthroughs in genetics over the last decade have radically advanced our understanding of the etiological basis of Parkinson's disease (PD). Although much research remains to be done, the main genetic causes of this neurodegenerative disorder are now partially unraveled, allowing us to feel m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clarimón, Jordi, Kulisevsky, Jaime
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924250/ https://www.ncbi.nlm.nih.gov/pubmed/24532987 http://dx.doi.org/10.2174/1389202914666131210212305

Ejemplares similares

Detection of genomic rearrangements from targeted resequencing data in Parkinson's disease patients
por: Spataro, Nino, et al.
Publicado: (2016)

Pharmacological management of Parkinson’s disease motor symptoms: update and recommendations from an expert
por: Kulisevsky, Jaime
Publicado: (2022)

A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice
por: Pagonabarraga, Javier, et al.
Publicado: (2020)

Tratamientos complementarios en la enfermedad de Parkinson
por: Kulisevsky, Jaime
Publicado: (2004)

Transtornos cognitivos y neuropsiquiátricos en la enfermedad de Parkinson /
por: Kulisevsky Bojarski, Jaime
Publicado: (2003)

Long-term Efficacy of Safinamide on Parkinson’s Disease Chronic Pain
por: Cattaneo, Carlo, et al.
Publicado: (2018)

Validation of a simple screening tool for early diagnosis of advanced Parkinson’s disease in daily practice: the CDEPA questionnaire
por: Martinez-Martin, Pablo, et al.
Publicado: (2018)

Tratamiento farmacológico de los síntomas motores de la enfermedad de Parkinson: actualización y recomendaciones de un experto
por: Kulisevsky, Jaime
Publicado: (2022)

MNCD: A New Tool for Classifying Parkinson’s Disease in Daily Clinical Practice
por: Santos García, Diego, et al.
Publicado: (2021)

Genetic testing for Parkinson’s disease in clinical practice
por: Gasser, Thomas
Publicado: (2023)

Impact of Infusion Therapies on Quality of Life in Advanced Parkinson’s Disease
por: Constantin, Viorelia A, et al.
Publicado: (2023)

The Genetics of Parkinson’s Disease and Implications for Clinical Practice
por: Day, Jacob Oliver, et al.
Publicado: (2021)

Erratum: Pagonabarraga, J.; et al. A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice. Brain Sci. 2020, 10, 176
por: Pagonabarraga, Javier, et al.
Publicado: (2020)

Consensus on the Definition of Advanced Parkinson's Disease: A Neurologists-Based Delphi Study (CEPA Study)
por: Luquin, Maria-Rosario, et al.
Publicado: (2017)

COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression
por: Santos-García, Diego, et al.
Publicado: (2016)

Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients
por: Clarimon, Jordi, et al.
Publicado: (2005)

Associations Between Diabetic Retinopathy and Parkinson's Disease: Results From the Catalonian Primary Care Cohort Study
por: Mauricio, Didac, et al.
Publicado: (2022)

Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression
por: Santos-García, Diego, et al.
Publicado: (2016)

Tremor Types in Parkinson Disease: A Descriptive Study Using a New Classification
por: Gironell, Alexandre, et al.
Publicado: (2018)

Facial Emotion Recognition Impairment in Patients with Parkinson's Disease and Isolated Apathy
por: Martínez-Corral, Mercè, et al.
Publicado: (2010)

Rotigotine transdermal patch and sleep in Parkinson’s disease: where are we now?
por: Rosa-Grilo, Miguel, et al.
Publicado: (2017)

The impact of dopaminergic treatment over cognitive networks in Parkinson's disease: Stemming the tide?
por: Aracil‐Bolaños, Ignacio, et al.
Publicado: (2021)

Safinamide in the treatment pathway of Parkinson’s Disease: a European Delphi Consensus
por: Stocchi, Fabrizio, et al.
Publicado: (2022)

Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson’s Disease
por: Pagonabarraga, Javier, et al.
Publicado: (2013)

A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease
por: Kulisevsky, Jaime, et al.
Publicado: (2022)

Parkinson's Disease: Impulsivity Does Not Cause Impulse Control Disorders but Boosts Their Severity
por: Marín-Lahoz, Juan, et al.
Publicado: (2018)

Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic
por: Sardi, S. Pablo, et al.
Publicado: (2018)

Clinical and Genetic Analysis of Costa Rican Patients With Parkinson's Disease
por: Torrealba-Acosta, Gabriel, et al.
Publicado: (2021)

Present and Future of Parkinson’s Disease in Spain: PARKINSON-2030 Delphi Project
por: Santos García, Diego, et al.
Publicado: (2021)

Genetics of Parkinson’s Disease - A Clinical Perspective
por: Cheon, Sang-Myung, et al.
Publicado: (2012)

Corrigendum: Clinical and genetic analysis of Costa Rican patients with Parkinson's disease
por: Torrealba-Acosta, Gabriel, et al.
Publicado: (2023)

Sudden unexpected death in Parkinson's disease: Insights from clinical practice
por: Scorza, Fulvio A., et al.
Publicado: (2022)

Pimavanserin Treatment for Parkinson's Disease Psychosis in Clinical Practice
por: Dashtipour, Khashayar, et al.
Publicado: (2021)

The Treatment of Sleep Disorders in Parkinson’s Disease: From Research to Clinical Practice
por: Loddo, Giuseppe, et al.
Publicado: (2017)

Transdermal Rotigotine Improves Sleep Fragmentation in Parkinson's Disease: Results of the Multicenter, Prospective SLEEP-FRAM Study
por: Pagonabarraga, Javier, et al.
Publicado: (2015)

Parkinson's disease in Practice
por: Gibson, J M
Publicado: (2002)

Genetics of Parkinson's disease
por: Gasser, Thomas
Publicado: (2004)

A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial(1)
por: Abbruzzese, Giovanni, et al.
Publicado: (2021)

Genetics of Cushing’s disease: from the lab to clinical practice
por: Theodoropoulou, Marily, et al.
Publicado: (2022)

GBA, Gaucher Disease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic Approaches
por: Riboldi, Giulietta M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_10osbqsvbgovkmm7ps2s12jje5